Skip to main content
Premium Trial:

Request an Annual Quote

Anachem to Distribute Kapa Biosystems PCR Reagents in UK


Anachem, a Mettler Toledo company, will exclusively distribute in the UK a range of PCR consumables from Kapa Biosystems, Anachem said recently.

Based in Woburn, Mass., Kapa Biosystems' molecular evolution technology platform is used to optimize enzymes for DNA amplification, next-generation DNA sequencing, and molecular diagnostic applications. These designer enzymes enable "new and improved applications that were not previously possible with generalist, wild-type enzymes," Anachem said.

Anachem, based in Luton, UK, and acquired by Mettler Toledo in 2010, is a specialist supplier of liquid-handling products and services to the laboratory community in the UK and Ireland.

In a statement, Anachem product manager Amy Jingzi Liu said that "for many years" Anachem has been advising scientists in UK molecular biology on PCR consumables as well as liquid-handling products. "We have already built a foundation of awareness and technology acceptance for Kapa in the UK, but under the exclusive agreement and with exciting new products continually being released, are very confident that we will deliver rapid additional growth," she said.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.